#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Rosai-Dorfman syndrome Pancreatic neuroendocrine tumour Central nervous system lymphoma Thalassaemia alpha Hyperinsulinism Atypical haemolytic uraemic syndrome B-cell lymphoma Juvenile chronic myelomonocytic leukaemia Glioblastoma Cortical dysplasia Chronic graft versus host disease in skin PIK3CA-activated mutation Waldenstrom's macroglobulinaemia recurrent Spinal cord injury Pelizaeus-Merzbacher disease More trials…

    Learn about Rare Diseases

    Hereditary ataxia – Life with Disease Carcinoid syndrome Loeys-Dietz syndrome – Trials in Disease Systemic mastocytosis – Diagnostics Langerhans cell sarcoma – Basic Information Synovial sarcoma metastatic – Diagnostics Pleural mesothelioma malignant – Life with Disease Chondrosarcoma – Basic Information Choroid melanoma – Basic Information Gastrointestinal stromal tumour – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Belinostat AB521 ALE1 Phenylalanine Cusatuzumab GSKVX000000017986 UDONITRECTAG Fosinopril Sodium Estradiol Navtemadlin Blu-451 Tabelecleucel Hydroxyzine Hydrochloride Ethinylestradiol Iptacopan Adrc001 Levothyroxine Sodium Dazodalibep Tadalafil PARECOXIB More therapies…

    Learn about Your Condition

    Mitochondrial myopathy Pancreatitis acute Brain stem glioma Mechanical ventilation Adrenogenital syndrome Hyperthyroidism Lung disorder Hyperlipidaemia Acarodermatitis Bipolar I disorder Muscle injury Hyperadrenocorticism Ovarian cancer metastatic Patent ductus arteriosus Colorectal cancer stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bacterial Infections and Mycoses

  • Study on the Effectiveness and Safety of High-Dose Rifampicin, Moxifloxacin, and Linezolid for Patients with Pulmonary Tuberculosis

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Pulmonary tuberculosis
    Investigated Drugs:
    • Linezolid
    • Moxifloxacin Hydrochloride
    • Thiamine Hydrochloride
    Spain

  • Study Comparing Rifampicin, Isoniazid, and Rifapentine Regimens for Treating Latent Tuberculosis in Patients with End-Stage Kidney Disease

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • End stage renal disease
    • Latent tuberculosis
    Investigated Drugs:
    • Pyridoxine
    • Rifapentine
    • Isoniazid
    Spain

  • Study on Vancomycin Hydrochloride for Treating Serious Infections in Critically Ill Adults Using a Precision Dosing Tool

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Critical illness
    Investigated Drugs:
    • Vancomycin Hydrochloride
    Estonia

  • Study on the Safety and Effectiveness of TP-102 for Treating Diabetic Foot Infections in Patients

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic foot infection
    Investigated Drugs:
    • F1245/05
    • F125/10
    • F44/10
    Poland

  • Study on the Effectiveness of Povidone-Iodine for Nasal Decolonization in Patients with MRSA

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Povidone, Iodinated
    France

  • Study on the Safety of Ceftolozane and Tazobactam for Children with Hospital-Acquired Pneumonia

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Ceftolozane
    • Tazobactam
    Estonia Greece Spain
Previous Page
1 … 41 42 43 44 45 46
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!